We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.25B
1-Year Est. Return 28.52%
This Fund
S&P 500
This Quarter Est. Return
-13.97%
1 Year Est. Return
+28.52%
3 Year Est. Return
+86.82%
5 Year Est. Return
+110.6%
10 Year Est. Return
+500.3%
AUM
$2.32B
AUM Growth
-$464M
Cap. Flow
-$25.6M
Cap. Flow %
-1.11%
Top 10 Hldgs %
20.12%
Holding
3,389
New
307
Increased
403
Reduced
666
Closed
334

Sector Composition

Rank Sector Weight
1 Technology 17.28%
2 Financials 9.97%
3 Healthcare 9.54%
4 Consumer Discretionary 9.4%
5 Industrials 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRTK
3301
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
-3,554
Closed -$11K
INFI
3302
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
-6,863
Closed -$8K
SURF
3303
DELISTED
Surface Oncology, Inc. Common Stock
SURF
-2,609
Closed -$8K
HARP
3304
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
-110
Closed -$5K
DMS
3305
DELISTED
Digital Media Solutions, Inc.
DMS
-16
Closed -$1K
IDEX
3306
DELISTED
Ideanomics, Inc. Common Stock
IDEX
-256
Closed -$36K
MTEM
3307
DELISTED
Molecular Templates, Inc.
MTEM
-143
Closed -$7K
SPPI
3308
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
-12,291
Closed -$16K
HGEN
3309
DELISTED
HUMANIGEN, INC.
HGEN
-3,517
Closed -$11K
NMTR
3310
DELISTED
9 Meters Biopharma
NMTR
-833
Closed -$10K
SQZ
3311
DELISTED
SQZ Biotechnologies Company
SQZ
-1,785
Closed -$9K
USX
3312
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
-1,727
Closed -$7K
EVLO
3313
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
-119
Closed -$8K
ONCR
3314
DELISTED
Oncorus, Inc.
ONCR
-1,601
Closed -$3K
FNCH
3315
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
-20
Closed -$3K
TCRR
3316
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
-2,165
Closed -$6K
LABP
3317
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
-52
Closed -$1K
SGTX
3318
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
-48
Closed -$1K
SDIG
3319
DELISTED
Stronghold Digital Mining, Inc. Class A Common Stock
SDIG
-57
Closed -$3K
CDAK
3320
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
-1,231
Closed -$8K
ISO
3321
DELISTED
IsoPlexis Corporation Common Stock
ISO
-650
Closed -$2K
SFT
3322
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
-487
Closed -$11K
RUBY
3323
DELISTED
Rubius Therapeutics, Inc
RUBY
-3,535
Closed -$19K
ATNX
3324
DELISTED
Athenex, Inc. Common Stock
ATNX
-300
Closed -$5K
HYRE
3325
DELISTED
HyreCar Inc. Common Stock
HYRE
-1,374
Closed -$3K

Similar funds

Ameritas Investment Partners's Q2 2022 Portfolio in Review

As of Q2 2022, Ameritas Investment Partners held 3,389 positions worth $2.32B, down 17% from $2.78B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Ameritas Investment Partners's Q2 2022 filing shows 307 new, 403 increased, 666 reduced and 334 closed positions. Its largest new stake was Aspen Technology Inc: 7,496 shares worth $1.38M. The largest sale was Camden Property Trust, an estimated $4.85M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

  • Ameritas Investment Partners's largest Q2 2022 buy was Aspen Technology Inc: 7,496 shares worth $1.38M.
  • Ameritas Investment Partners added most to Invesco QQQ Trust in Q2 2022, an estimated $3.81M increase.
  • Ameritas Investment Partners's biggest Q2 2022 reduction was Camden Property Trust, cutting an estimated $4.85M.
  • Ameritas Investment Partners fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $2.95M.
  • Ameritas Investment Partners's ten largest holdings make up 20% of its $2.32B portfolio in Q2 2022.
  • Ameritas Investment Partners opened 307 new positions and closed 334 in Q2 2022.
  • Ameritas Investment Partners's portfolio value fell 17% quarter-over-quarter to $2.32B.

Based on Ameritas Investment Partners's 13F filing for Q2 2022, filed 12 Aug 2022.